NCT00410540View on ClinicalTrials.gov

A Study of OROS Hydromorphone HCL vs Morphine in Cancer Pain Patients.

PHASE3CompletedINTERVENTIONAL
Enrollment

202

Participants

Timeline

Start Date

Not specified

Study Completion Date

May 31, 2001

Conditions
PainAnalgesics, Opioid
Interventions
DRUG

OROS hydromorphone HCL ; Morphine sulfate

All Listed Sponsors
lead

Alza Corporation, DE, USA

INDUSTRY

NCT00410540 - A Study of OROS Hydromorphone HCL vs Morphine in Cancer Pain Patients. | Biotech Hunter | Biotech Hunter